IASFF ImaSight Corp featured news, full reports, and detailed charts
ImaSight Corp (IASFF/IASFF.PK) Wrap Up:
ImaSight Corp. develops and supplies digital radiography solutions for human and animal healthcare. The company offers a digital sensor for x-ray systems that replaces traditional film-based technology. Its product includes ImaSight 4600 digital x-ray system that captures the light generated by a conventional x-ray source in a patented optical design. The company, through a strategic relationship with Cedara Software, provides its own diagnostic view processing software for the ImaSight 4600 system. It markets its product to small- to medium-sized medical clinics, chiropractic practices, and veterinary hospitals that utilize x-ray systems for diagnosis. The company was founded in 2001 and is...ImaSight Corp (IASFF:Pink OTC Markets Inc)
Snapshot of ImaSight Corp (IASFF)
|
OPEN
--
|
PREVIOUS CLOSE
$0.02
|
|
|
DAY HIGH
--
|
DAY LOW
--
|
|
|
52 WEEK HIGH
12/4/08 - $0.03
|
52 WEEK LOW
02/10/09 - $0.0024
|
|
|
MARKET CAP
80.9K
|
AVERAGE VOLUME 3 mo
0.0
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
4.4M
|
|
|
IASFF Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
IASFF Top Compensated Officers
Executives, Board Directors
Key developments for ImaSight Corp (IASFF)
Effective to the close of business, July 13, 2009, and in accordance with exchange Policy 2.9, ImaSight Corp.’s securities will be delisted from the TSX Venture Exchange, for failure to pay its annual sustaining fees. Prior to delisting the company's securities were subject to a suspension from trading.
ImaSight Corp. announced Unaudited sales results for the fiscal year ended December 31, 2008. For the period the company reported net unaudited sales of $1.14 million compared to no sales revenue the previous year. All revenues were from the sale of digital x-ray sensors. The company also received a verbal indication from PricewaterhouseCoopers, auditors, that they do not wish to continue their engagement. The company anticipates that it will be unable to meet the requirement to file audited statements by May 1, 2009. There are no accounting issues in dispute between the company and PricewaterhouseCoopers.
ImaSight Corp. announced that it will permanently close its Liponex biopharm division.
IASFF Competitors
| Company | Last | Change | |
| No competitor information is available for IASFF. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | IASFF | Industry Range |
| No financial data is available for IASFF. | ||
IASFF transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||